ProfileGDS5822 / ILMN_2739287
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 99% 99% 98% 99% 99% 99% 99% 98% 98% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 14381.699
GSM1276600PDAC Late Ablation Control 2399199
GSM1276601PDAC Late Ablation Control 33588.798
GSM1276602PDAC Late Ablation 1424899
GSM1276603PDAC Late Ablation 24279.999
GSM1276604PDAC Late Ablation 36239.399
GSM1303940PDAC Late Ablation_anti-CTLA4 15307.899
GSM1303941PDAC Late Ablation_anti-CTLA4 23441.698
GSM1303942PDAC Late Ablation_anti-CTLA4 33975.398